We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+14.92%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$15.4B
AUM Growth
+$3.5B
Cap. Flow
+$2.17B
Cap. Flow %
14.1%
Top 10 Hldgs %
61.13%
Holding
135
New
34
Increased
38
Reduced
18
Closed
39

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$405M
2
SKX
Skechers
SKX
+$402M
3
UNH icon
UnitedHealth
UNH
+$373M
4
HES
Hess
HES
+$203M
5
INFA
Informatica
INFA
+$141M

Top Sells

Rank Stock Value
1
X
US Steel
X
+$814M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$685M
3
BA icon
Boeing
BA
+$231M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$212M
5
HEES
H&E Equipment Services
HEES
+$156M

Sector Composition

Rank Sector Weight
1 Healthcare 9.53%
2 Industrials 9.28%
3 Technology 6.84%
4 Energy 6.69%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
X
126
PUT
DELISTED
US Steel
X
– –
-8,668,800
Closed -$366M
VIK icon
127
Viking Holdings
VIK
$47.2B
– –
-20,000
Closed -$795K
VRN
128
DELISTED
Veren
VRN
– –
-2,006,000
Closed -$13.3M
CRWV
129
CoreWeave
CRWV
$49.5B
– –
-15,000
Closed -$556K
BECN
130
DELISTED
Beacon Roofing Supply, Inc.
BECN
– –
-108,000
Closed -$13.4M
FNA
131
DELISTED
Paragon 28, Inc.
FNA
– –
-900,000
Closed -$11.8M
ATSG
132
DELISTED
Air Transport Services Group
ATSG
– –
-732,755
Closed -$16.4M
ITCI
133
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-5,190,000
Closed -$685M
SWI
134
DELISTED
SolarWinds Corporation Common Stock
SWI
– –
-1,201,358
Closed -$22.1M
2 3 4 5
6

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Pentwater Capital Management held 135 positions worth $15.4B, up 29% from $11.9B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Pentwater Capital Management deployed $2.17B of net new capital in Q2 2025, opening 34 new positions and adding to 38 existing holdings. Its largest new stake was Blueprint Medicines: 3,900,000 shares worth $500M.

By sector, the portfolio is most concentrated in Healthcare at 9.5% of assets, up from 8.1% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Boeing, an estimated $231M trimmed.

  • Pentwater Capital Management's largest Q2 2025 buy was Blueprint Medicines: 3,900,000 shares worth $500M.
  • Pentwater Capital Management added most to Hess in Q2 2025, an estimated $203M increase.
  • Pentwater Capital Management's biggest Q2 2025 reduction was Boeing, cutting an estimated $231M.
  • Pentwater Capital Management fully exited US Steel in Q2 2025, selling an estimated $814M.
  • Pentwater Capital Management's ten largest holdings make up 61% of its $15.4B portfolio in Q2 2025.
  • Pentwater Capital Management opened 34 new positions and closed 39 in Q2 2025.
  • Pentwater Capital Management's portfolio value rose 29% quarter-over-quarter to $15.4B.

Based on Pentwater Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.